Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 176 for “"Tauopathies"”.
-
Structural and functional imaging of tauopathies
… ¹¹C-PBB3 is a viable tracer for use in other tauopathies, including CTE. Longitudinal studies with combined DTI and PET are necessary to elucidate the potentially synergistic interactions between damage to white matter tracts, tau accumulation, inflammation, and the initiation of processes …
-
Investigation of neurodegenerative tauopathies using caenorhabditis elegans
Neurodegenerative tauopathies are a class of neurodegenerative disease characterized by the accumulation of tau protein into neurofibrillary tangles in the human brain. Alzheimer's disease (AD) is one such tauopathy. Until recently, the amyloid Îø hypothesis, suggesting that accumulation of amyloid …
-
Regulation of retromer and its role in tauopathies
… late-onset neurodegenerative diseases termed tauopathies, including Alzheimer’s disease. However, whether retromer dysfunction directly contributes to tau aggregation and neurotoxicity remains unclear. Altogether, this work illustrates how retromer regulates the clearance of tau via the …
-
Neuropsychiatric features of parkinsonian tauopathies and alpha-synucleinopathies.
… can differentiate parkinsonian patients with: tauopathies from those with alpha-synucleinopathies and explore caregiver distress. Three hundred and four patients (62 with tauopathies and 242 with alpha-synucleinopathies) diagnosed according to published diagnostic criteria were evaluated using …
-
Modeling tauopathies in vitro with diverse aggregation inducing techniques
The microtubule-associated protein tau promotes the stabilization of the axonal cytoskeleton in neurons. In several neurodegenerative diseases, such as Alzheimer’s disease, Pick’s disease, corticobasal degeneration, chronic traumatic encephalopathy, and progressive supranuclear palsy, tau has been …
-
Targeting the Hsp90/Aha1 Complex for the Treatment of Tauopathies
… are the hallmarks of many diseases known as tauopathies. The heat shock protein 90 kDa (Hsp90) chaperone network is highly involved in modulating client proteins, including tau. However, during aging and disease the Hsp90 chaperone network becomes highly imbalanced with some …
-
Neurodegenerative tauopathies disrupt neuronal function and circadian behaviour in Drosophila
Tauopathies are progressive neurodegenerative diseases characterised by the aggregation of hyperphosphorylated tau protein into neurofibrillary tangles (NFTs). To date, the majority of research has focused on NFT formation and neuronal death. However, mounting evidence suggests that clinical …
-
Dissecting Tau Isoform Control and Modeling Tauopathies in Directly-Reprogrammed Neurons
Tauopathies are a family of neurodegenerative disorders whose pathology include intracellular tau aggregates, synaptic dysfunction, and neuronal death. Advanced age is the strongest risk factor for developing a tauopathy, independent of a predisposing mutation, therefore the ability to study …
-
Targeting Tau Degradation by Small Molecule Inhibitors for Treatment of Tauopathies
Tauopathies are neurodegenerative diseases that affect millions of people around the world. Tauopathies include more than 20 neurodegenerative diseases. Some of the most common tauopathies are Alzheimer’s disease (AD), frontotemporal dementia (FTD), chronic traumatic encephalopathy (CTE), Pick’s …
-
THE ROLE OF ANTI-INFLAMMATORY CYTOKINE INTERLEUKIN-10 (IL-10) IN TAUOPATHIES
Tauopathies are neurodegenerative diseases, including Alzheimer’s disease, that are associated with pathological accumulation of the microtubule associated protein tau (MAPT, or tau) (Lee et al., 2001). Abnormal hyperphosphorylated tau (pTau) strongly correlate with cognitive impairment (Nelson et …
-
Tauopathies, Novel Optogenetic Tools, and the Future of Artificial Intelligence in Medicine
… hallmark of Alzheimer’s disease (AD) and related tauopathies. Attempts have been made to promote clearance of pathological tau (p-Tau) from neurons via autophagy. Transcription factor EB (TFEB) has shown to clear p-Tau from neurons via autophagy. However, sustained TFEB activation and autophagy …
-
The Role Of Tau Strains In Generating The Diversity Of Human Tauopathies
Neurodegenerative tauopathies are characterized by the abnormal accumulation of tau protein inside neural cells. The most common neurodegenerative disease, Alzheimer’s disease (AD), is one such tauopathy, in which tau tangles contribute to both the neurodegeneration and clinical progression of the …
-
Impact of Microbiota on Neurodegeneration in Tauopathies using Caenorhabditis elegans as a Model Organism
… We examined the effects of human microbiota in tauopathies, a class of age-associated neurodegenerative diseases that are characterized by the accumulation of tau protein inclusions. Using a Caenorhabditis elegans model expressing an aggregate prone human tau protein, we examined the influence …
-
Protein Kinase CK2alpha prime: A Unifying Regulator and Therapeutic Candidate in PolyQ Expansion Disorders and Tauopathies
… in HD. CK2 has also been heavily implicated in tauopathies, including AD and other AD related dementias (ADRD) such as FTD, which are characterized by the abnormal accumulation of phosphorylated Tau (pTau). We demonstrate a subunit specific elevation of CK2α’ in ADRD patient tissues associated …
-
Identify Signature Genes/Pathways to Characterize Alzheimer's Disease Subtypes Based on Uncoupled Tauopathies and Cognitive Decline
Alzheimer's disease (AD) is a slow-progressing dementia usually found in elderlies, with heterogeneous clinical phenotypes and possible underlying mechanisms. Widely spread tauopathy is one of the pathological change hallmarks in AD brains, in which microtube protein tau forms scar-like …
-
Using Human Brain Tissue to Characterise Primary Tauopathy in a New Zealand Cohort
Primary tauopathies are a group of neurodegenerative disorders characterised by the pathological intracellular deposition of the tau protein. Pathologically, tauopathies are defined by differences in tau isoform composition, morphology, cell-type specific inclusions, and neuroanatomical …
-
On the Structure and Function of Tau Assemblies in Neurodegenerative Diseases
Tauopathies, a group of neurodegenerative diseases characterized by aggregation of tau protein, are heterogeneous clinically and pathologically. Recent cryo-EM studies of tau filaments derived from diseased brains have confirmed that most tauopathies are associated with a unique fold, or strain, of …
-
Tau Prion Strains in Cells, Mice, and Patients
… along neuronal networks in neurodegenerative tauopathies such as Alzheimer’s disease. It has become increasingly clear that unique conformations (“strains”) of prion protein (PrP) link aggregate structure to clinical phenotypes in human prion diseases. Intriguingly, vast phenotypic diversity …
-
MIRNA-22 3p AND ITS ROLE IN TAU PHOSPHORYLATION
… in death. A subset of these diseases is called tauopathies. Tauopathies are characterized by a filamentous accumulation of hyper-phosphorylated tau, in neurons and glial cells. Currently, it is unknown how tau becomes hyper-phosphorylated and/or it accumulates in the brain. Tau is a highly …
-
Modifications of the tau protein and their varied effects on aggregation and function
… Alzheimer's disease, collectively known as tauopathies. In these diseases tau dissociates from microtubules and begins to polymerize into aggregates that are typically fibrillary in nature. The deposition of these aggregates is closely linked to the death and dysfunction of neurons and …
Page 1 of 9